Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02234986
Title A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors CASI Pharmaceuticals, Inc.
Indications

fibrolamellar carcinoma

Therapies

ENMD-2076

Age Groups: adult
Covered Countries USA


No variant requirements are available.